A chance to end the world HIV epidemic: low -cost preventive medication is launched on 2027
Generic versions of an HIV injectable revolutionary prevention drug should be available for $ 40 per year in more than 100 countries from 2027, according to Unitaid and the Gates Foundation. The two organizations have concluded separate agreements with Indian pharmaceutical companies to produce cheaper generic versions of Lenacapavir – a twice annual injection has shown the risk of HIV transmission of more than 99.9% – for low and medium -income countries. Details of Unitaid Executive Directive Philippe DUNTON.
[og_img]
About The Author
